Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a mixed picture: strong shareholder returns via buybacks and dividends, but financials show declining revenue and a net loss due to impairment charges. The Q&A highlights resilience in administrative fees and supply chain strategies but also reveals uncertainties regarding tariffs and consulting services. Given the stable guidance and mixed financial performance, the stock is likely to remain neutral, with potential slight fluctuations due to market sentiment.
Net Revenue $240 million, decreased from the prior year period; driven by a decline in net administrative fees revenue in Supply Chain Services and lower revenue in consulting services.
GAAP Net Loss from Continuing Operations $46 million, mainly due to an impairment charge to goodwill of $127 million related to the data and technology business in the Performance Services segment.
Adjusted EBITDA $50 million, translating to a margin of 20.8%, declined largely due to lower revenue.
Adjusted Earnings Per Share (EPS) $0.25; excluding the impact of Contigo Health was $0.27, in line with expectations; benefited from a lower weighted average share count due to share repurchases.
Free Cash Flow $74 million, increased by $33 million from the prior year period; driven by cash received from a derivative lawsuit settlement and distribution from a minority investment.
Cash and Cash Equivalents $86 million as of December 31, 2024.
Outstanding Balance on Revolving Credit Facility $100 million on a $1 billion facility, with $65 million to be paid in January.
Quarterly Dividend $42 million in the first half of fiscal year 2025, representing a 4% yield in calendar year 2024.
Share Repurchase Completed a $200 million share repurchase in early January 2025.
Digital Supply Chain Strategy: Successful transition of our digital supply chain strategy beyond the pilot phase marked by the signing of our first agreement with a major partner.
AI-Enabled Processes: AI enabling manual back office processes for providers and suppliers delivering significant time improvement and cost savings.
Performance Services Leadership: Welcoming David Zito as the new President of Performance Services, bringing 40 years of healthcare consulting expertise.
Market Intelligence Demand: Growing demand for Premier’s provider-focused data, market intelligence, and expertise in navigating the 503B program.
New Member Acquisition: Added new members, including AllSpire Health Partners, a recent competitive GPO win.
Free Cash Flow: Free cash flow of $74 million increased by $33 million from the prior year period.
Share Repurchase: Repurchased over 29 million shares of Class A common stock for $600 million.
Revenue Guidance: Reaffirming total net revenue guidance and increasing adjusted earnings per share guidance.
Performance Services Strategy: Plans to reinvigorate Performance Services by recruiting new talent and refocusing solutions.
Earnings Expectations: Premier, Inc. missed earnings expectations with a reported EPS of $0.25 compared to the expected $0.29.
Revenue Decline: Net revenue of $240 million for the quarter decreased from the prior year, driven by a decline in net administrative fees revenue in Supply Chain Services and lower revenue in consulting services.
Impairment Charge: GAAP net loss from continuing operations of $46 million was mainly due to an impairment charge to goodwill of $127 million related to the data and technology business in the Performance Services segment.
Performance Services Challenges: The Performance Services segment experienced a 19% revenue decline due to lower demand in consulting services and an unfavorable product mix.
Supply Chain Services Risks: The expected increase in the aggregate blended fee share to the low 60% level negatively impacted year-over-year results.
Market Competition: There is a gradual shift in member interest favoring SaaS subscription engagements versus license agreements, indicating competitive pressures in the market.
Economic Factors: The company is navigating a dynamic healthcare landscape, which presents ongoing economic challenges.
Digital Supply Chain Strategy: Successful transition beyond pilot phase with first agreement signed with a major partner, leveraging clinical and supply chain data for innovation.
AI and Automation: AI enabling manual back office processes for providers and suppliers, delivering significant time improvement and cost savings.
Data Enhancement: Enhancing data to provide a comprehensive view of total non-labor healthcare spend for actionable performance improvement insights.
Supply Chain Transparency: Enhancing transparency to help anticipate and address potential shortages before impacting patient care.
Leadership Change: Welcoming David Zito as President of Performance Services to drive innovation and growth.
Market Intelligence: Growing demand for provider-focused data and expertise in navigating the 503B program.
Revenue Guidance: Reaffirming total net revenue guidance and increasing midpoint of Supply Chain Services revenue guidance by $25 million.
Adjusted EPS Guidance: Increasing midpoint of adjusted earnings per share guidance by $0.08 due to share repurchase.
Performance Services Revenue Guidance: Lowering midpoint of Performance Services revenue guidance by $25 million due to short-term headwinds.
Adjusted EBITDA Guidance: Tightening ranges and reaffirming midpoint of adjusted EBITDA guidance.
Cash Flow: Free cash flow of $74 million for the first half of fiscal year 2025, an increase of $33 million from the prior year.
Quarterly Dividend: The Board declared a dividend of $0.21 per share payable in March 2025, totaling $42 million in the first half of fiscal year 2025.
Share Repurchase Program: Completed a $200 million share repurchase in early January 2025, with over 29 million shares repurchased for $600 million under a $1 billion authorization.
The earnings call reveals strong financial performance, with increased guidance for EBITDA and EPS, and a strategic partnership with Epic. The Q&A highlights growth in advisory services and stable supply chain conditions. Despite some vague responses, the company's strategic initiatives and optimistic guidance suggest a positive stock movement. The market cap indicates a moderate reaction, leading to a prediction of a positive stock price movement (2% to 8%) over the next two weeks.
The earnings call presents a mixed picture: strong financial metrics with increased adjusted EPS and EBITDA, but lower net revenue and challenges in Performance Services. The Q&A highlights concerns about rising costs, tariffs, and workforce shortages. Positive factors include a share repurchase program and dividend yield, but these are offset by uncertainties in revenue guidance and macroeconomic pressures. Given the company's market cap and the balanced positive and negative elements, a neutral stock price movement is expected over the next two weeks.
The earnings call presents a mixed picture: strong shareholder returns via buybacks and dividends, but financials show declining revenue and a net loss due to impairment charges. The Q&A highlights resilience in administrative fees and supply chain strategies but also reveals uncertainties regarding tariffs and consulting services. Given the stable guidance and mixed financial performance, the stock is likely to remain neutral, with potential slight fluctuations due to market sentiment.
The earnings call indicates mixed signals: financial performance declined YoY, but there was a notable gain from a lawsuit settlement. The company announced a significant share repurchase and dividend payout, which are positive. However, management's vague responses on certain issues during the Q&A, coupled with an 8% revenue decline, suggest uncertainty. The market cap indicates a moderate reaction, resulting in a neutral stock price prediction.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.